The modified Glasgow score, serving as an inflammation and nutrition-based prognostic score, which combines CRP and albumin levels (CRP ≤ 10 mg/L + albumin ≥ 35 g/L; CRP ≤ 10 mg/L + albumin < 35 g/L; CRP > 10 mg/L or CRP > 10 mg/L + albumin < 35 g/L), has been shown to be significantly associated with overall survival, independently from cancer extension or cancer treatment [4]. The gene discussed is ALB; the disease is cancer.